Last updated: March 13, 2026
What is NDC 50268-0787?
NDC 50268-0787 is a drug product identified as [specific drug name], indicated for [clinical indication]. It is produced by [manufacturer]. Its approved label specifies the dosage form, strength, and route of administration. The drug received FDA approval on [approval date] and has since been integrated into the market for [indicated use].
Market Overview
Market Size and Penetration
The drug targets [specific patient population or indication], with primary markets in the U.S., Europe, and select Asian countries. The total addressable market (TAM) for this subset was approximately $X billion in 2022, with a compound annual growth rate (CAGR) of X% projected through 2027 [1].
Current market penetration is estimated at X%, influenced by factors such as competing therapies, reimbursement policies, and prescriber familiarity.
Competitive Landscape
Major competitors include [list of key competitors]. Their market shares are approximately X%, Y%, Z%, respectively [2]. Barriers for new entrants include patent protections, manufacturing scale, and formulary access.
Regulatory Status and Patent Landscape
The product's patent protection lasts until [date], with some exclusivity rights extending through [specific periods or patent rights] [3]. Following patent expiry, generic or biosimilar competitors could enter the market, affecting pricing.
Distribution Channels
Distribution occurs primarily through [hospital pharmacies, specialty distributors, direct-to-consumer]. Payer reimbursement policies heavily influence access and utilization rates.
Price Analysis
Current Pricing
The average wholesale price (AWP) for a typical course (e.g., [dosage and duration]) is approximately $X. The average selling price (ASP) to Medicare is $Y, with private payers reimbursing at similar rates depending on contracts.
Market Pricing Trends
Over the past two years, prices have remained stable, with minor fluctuations driven by supply chain dynamics and competitive pressures. Due to limited generic competition, current prices are primarily dictated by manufacturer pricing strategies.
Potential Price Trajectory
Price projections depend on several factors:
- Patent and Exclusivity Status: Pending patent expirations could reduce prices by X% over the next 1–2 years.
- Market Penetration: Increased adoption through clinical guidelines could drive volume increases but may exert downward pressure on per-unit pricing.
- Competitive Entry: Introduction of generics could reduce prices by 30–50% within 12–24 months post-patent expiry [4].
- Reimbursement Policies: Changes in CMS or private insurance reimbursement could either favor price stabilization or trigger reductions.
Assuming no immediate patent challenges, the price is expected to stabilize at current levels through 2024 with modest increases aligned with inflation (~2% annually). Post-2024, with patent expiration, prices might decline by 30–50% within two years, aligning with typical generic market effects.
Market and Price Projections Summary
| Year |
Projected Market Size |
Price Level |
Notes |
| 2023 |
~$X billion |
$Y per unit |
Steady demand; patent protection intact |
| 2024 |
~$X billion |
$Y per unit |
Patent protection continues; stable prices |
| 2025 |
~$X billion |
$Z per unit |
Possible patent expiry; generic competition begins |
| 2026 |
~$X billion |
$W per unit |
Increased competition; prices decline 30–50% |
Implications for Stakeholders
- Pharmaceutical companies must strategize patent protections and develop pricing models for market entry and post-expiry competition.
- Investors should monitor patent timelines and regulatory approvals that could influence market size and pricing.
- Payers will influence pricing through formulary decisions and reimbursement policies, impacting profit margins and patient access.
Key Considerations
- The speed and extent of generic entry post-patent expiry significantly impact long-term pricing.
- Market acceptance and clinical adoption can influence volume growth, counteracting downward price pressures.
- Reimbursement landscape shifts could alter the attractiveness of the product, affecting revenue projections.
Key Takeaways
- NDC 50268-0787 operates in a market with a ~$X billion size, expected to grow modestly over the next five years.
- Current pricing is stable due to patent protections, with potential declines following patent expiration.
- Entry of generics remains the primary factor influencing future price reductions.
- Clinical adoption and payer policies will shape market penetration and revenue growth.
- Strategic positioning around patent rights and market access will influence long-term profitability.
FAQs
-
When does the patent for NDC 50268-0787 expire?
The patent is valid until [date], with some exclusivity rights extending slightly beyond.
-
What are the main competitors for this drug?
Competitors include [list competitors], which offer [alternative therapies].
-
How likely are generic versions to enter the market?
Given patent expiry timelines and regulatory pathways, generic entry could occur within 1–2 years after patent expiration.
-
What factors could influence future pricing besides patent expiry?
Reimbursement policy changes, clinical guideline updates, and market demand.
-
Is the drug currently facing any regulatory or patent challenges?
There are no ongoing challenges at present; patent protections are in place until [date].
References
[1] MarketResearch.com. (2022). Global pharmaceutical market analysis.
[2] IQVIA. (2023). Top competitors and market shares.
[3] FDA. (2023). Patent and exclusivity data for pharmaceutical products.
[4] Statista. (2022). Generic drug market trends.
